Area of research
Psychiatry and Mental health · Physiology
Research interest
Research focused on Donepezil and Disease, with related work in Placebo, Randomized controlled trial, Alzheimer's disease. Notable publications include 'Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints...', 'MAPT STUDY: A MULTIDOMAIN APPROACH FOR PREVENTING ALZHEIMER’S DISEASE: DESIGN AND BASELINE DATA', and 'Reduced basal forebrain atrophy progression in a randomized Donepezil trial in prodromal Alzheimer’s disease'.
The association of diabetes with Alzheimer's disease biomarkers and vascular burden across European aging and memory clinic cohorts
Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial
Reduced basal forebrain atrophy progression in a randomized Donepezil trial in prodromal Alzheimer’s disease
Added value of <sup>18</sup>F‐florbetaben amyloid PET in the diagnostic workup of most complex patients with dementia in France: A naturalistic study
Reduced Regional Cortical Thickness Rate of Change in Donepezil-Treated Subjects With Suspected Prodromal Alzheimer’s Disease
MAPT STUDY: A MULTIDOMAIN APPROACH FOR PREVENTING ALZHEIMER’S DISEASE: DESIGN AND BASELINE DATA
Impact of harmonization of collection tubes on Alzheimer's disease diagnosis